| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Prostate-Specific Antigen | 3 | 2018 | 213 | 1.00 | Why? |
| Decision Making | 6 | 2019 | 3132 | 0.70 | Why? |
| Prostatic Neoplasms | 3 | 2018 | 1637 | 0.68 | Why? |
| Pharyngitis | 2 | 2017 | 687 | 0.63 | Why? |
| Choice Behavior | 1 | 2018 | 319 | 0.56 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.51 | Why? |
| Evidence-Based Medicine | 5 | 2020 | 3228 | 0.51 | Why? |
| Early Detection of Cancer | 4 | 2019 | 1956 | 0.50 | Why? |
| Randomized Controlled Trials as Topic | 15 | 2021 | 10649 | 0.48 | Why? |
| Risk Adjustment | 1 | 2017 | 730 | 0.48 | Why? |
| Decision Support Systems, Clinical | 1 | 2017 | 551 | 0.47 | Why? |
| Publishing | 2 | 2019 | 990 | 0.45 | Why? |
| Patient Preference | 1 | 2018 | 750 | 0.44 | Why? |
| Adrenal Cortex Hormones | 5 | 2020 | 6537 | 0.42 | Why? |
| Enoxaparin | 1 | 2017 | 1064 | 0.41 | Why? |
| Observational Studies as Topic | 1 | 2017 | 1887 | 0.38 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.36 | Why? |
| Information Dissemination | 2 | 2020 | 2986 | 0.34 | Why? |
| Fracture Healing | 2 | 2017 | 37 | 0.34 | Why? |
| Ultrasonic Therapy | 2 | 2017 | 43 | 0.33 | Why? |
| Practice Guidelines as Topic | 10 | 2019 | 15421 | 0.33 | Why? |
| Post-Exposure Prophylaxis | 2 | 2021 | 472 | 0.31 | Why? |
| Foramen Ovale, Patent | 2 | 2018 | 153 | 0.30 | Why? |
| Hospitals, University | 1 | 2018 | 4173 | 0.30 | Why? |
| Guideline Adherence | 2 | 2020 | 2309 | 0.30 | Why? |
| Network Meta-Analysis | 4 | 2020 | 426 | 0.28 | Why? |
| Mass Screening | 3 | 2019 | 8005 | 0.27 | Why? |
| Platelet Aggregation Inhibitors | 3 | 2018 | 1671 | 0.26 | Why? |
| Anticoagulants | 3 | 2018 | 9563 | 0.23 | Why? |
| Communication | 1 | 2018 | 5206 | 0.21 | Why? |
| Respiratory Care Units | 1 | 2021 | 111 | 0.21 | Why? |
| Carrageenan | 1 | 2021 | 123 | 0.20 | Why? |
| Sigmoidoscopy | 1 | 2019 | 50 | 0.20 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.20 | Why? |
| Shoulder Impingement Syndrome | 1 | 2019 | 6 | 0.20 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.20 | Why? |
| Chemoprevention | 2 | 2021 | 585 | 0.19 | Why? |
| Shoulder Pain | 1 | 2019 | 36 | 0.19 | Why? |
| Decompression, Surgical | 1 | 2019 | 114 | 0.18 | Why? |
| Spinal Puncture | 1 | 2018 | 95 | 0.17 | Why? |
| Needles | 1 | 2018 | 87 | 0.17 | Why? |
| Lopinavir | 3 | 2020 | 4308 | 0.17 | Why? |
| Ultrasonic Waves | 1 | 2017 | 32 | 0.17 | Why? |
| Random Allocation | 2 | 2018 | 773 | 0.17 | Why? |
| Lower Urinary Tract Symptoms | 1 | 2018 | 116 | 0.17 | Why? |
| Arthroscopy | 1 | 2017 | 46 | 0.17 | Why? |
| Thyroid Hormones | 1 | 2019 | 213 | 0.17 | Why? |
| Ritonavir | 3 | 2020 | 4212 | 0.17 | Why? |
| Hypothyroidism | 1 | 2019 | 239 | 0.16 | Why? |
| Occult Blood | 1 | 2019 | 275 | 0.16 | Why? |
| Tonsillitis | 1 | 2017 | 67 | 0.16 | Why? |
| Selection Bias | 1 | 2017 | 201 | 0.16 | Why? |
| Research Design | 5 | 2021 | 5830 | 0.15 | Why? |
| Prosthesis Failure | 1 | 2017 | 195 | 0.15 | Why? |
| Emotions | 2 | 2018 | 2418 | 0.15 | Why? |
| Internal Medicine | 2 | 2019 | 557 | 0.15 | Why? |
| Abscess | 1 | 2018 | 234 | 0.15 | Why? |
| Knee Joint | 1 | 2017 | 194 | 0.14 | Why? |
| Thrombosis | 1 | 2017 | 7504 | 0.14 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.14 | Why? |
| Hydroxychloroquine | 5 | 2021 | 12447 | 0.14 | Why? |
| Stroke | 4 | 2018 | 8839 | 0.14 | Why? |
| Patient Outcome Assessment | 1 | 2019 | 707 | 0.14 | Why? |
| Comprehension | 1 | 2018 | 259 | 0.14 | Why? |
| Osteoarthritis | 1 | 2017 | 205 | 0.14 | Why? |
| Osteoarthritis, Knee | 1 | 2017 | 158 | 0.14 | Why? |
| Humans | 57 | 2021 | 930598 | 0.14 | Why? |
| Ischemic Attack, Transient | 1 | 2018 | 439 | 0.14 | Why? |
| Bias | 2 | 2017 | 1109 | 0.14 | Why? |
| Switzerland | 5 | 2021 | 2738 | 0.14 | Why? |
| Authorship | 1 | 2017 | 240 | 0.14 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.13 | Why? |
| Brain Ischemia | 2 | 2018 | 2813 | 0.12 | Why? |
| Colonoscopy | 1 | 2019 | 738 | 0.12 | Why? |
| Surgical Wound Infection | 1 | 2018 | 501 | 0.12 | Why? |
| Telemedicine | 2 | 2020 | 25032 | 0.12 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2021 | 1138 | 0.11 | Why? |
| Myocardial Infarction | 2 | 2018 | 3361 | 0.11 | Why? |
| Ivermectin | 1 | 2021 | 973 | 0.11 | Why? |
| Body Weight | 1 | 2017 | 1074 | 0.11 | Why? |
| Heart Valve Prosthesis | 1 | 2017 | 533 | 0.11 | Why? |
| Checklist | 1 | 2017 | 714 | 0.11 | Why? |
| Fractures, Bone | 1 | 2017 | 487 | 0.11 | Why? |
| Aortic Valve | 1 | 2017 | 664 | 0.11 | Why? |
| Sepsis | 2 | 2018 | 3517 | 0.11 | Why? |
| Antiviral Agents | 5 | 2021 | 41703 | 0.10 | Why? |
| Defibrillators, Implantable | 1 | 2017 | 624 | 0.10 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.10 | Why? |
| Aspirin | 1 | 2018 | 1043 | 0.10 | Why? |
| Cardiac Catheterization | 1 | 2017 | 882 | 0.10 | Why? |
| Bibliometrics | 1 | 2017 | 731 | 0.10 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.10 | Why? |
| Drug Monitoring | 1 | 2017 | 1408 | 0.09 | Why? |
| Aortic Valve Stenosis | 1 | 2017 | 741 | 0.09 | Why? |
| Smartphone | 1 | 2020 | 1840 | 0.09 | Why? |
| Chronic Pain | 1 | 2017 | 736 | 0.09 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.09 | Why? |
| Transcatheter Aortic Valve Replacement | 1 | 2017 | 839 | 0.09 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2017 | 1731 | 0.09 | Why? |
| Trust | 1 | 2019 | 1487 | 0.09 | Why? |
| Clinical Decision-Making | 2 | 2021 | 3755 | 0.09 | Why? |
| Noninvasive Ventilation | 1 | 2021 | 2329 | 0.09 | Why? |
| Cardiomyopathies | 1 | 2017 | 997 | 0.09 | Why? |
| Analgesics, Opioid | 1 | 2017 | 1070 | 0.08 | Why? |
| Drug Combinations | 3 | 2020 | 3852 | 0.08 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.08 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.08 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.08 | Why? |
| Dexamethasone | 1 | 2017 | 2055 | 0.08 | Why? |
| Sleep Initiation and Maintenance Disorders | 1 | 2018 | 1692 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Adenosine Monophosphate | 2 | 2020 | 5652 | 0.08 | Why? |
| Alanine | 2 | 2020 | 5687 | 0.08 | Why? |
| Colorectal Neoplasms | 1 | 2019 | 1884 | 0.07 | Why? |
| Health Equity | 1 | 2017 | 1223 | 0.07 | Why? |
| Patient Readmission | 1 | 2014 | 1543 | 0.07 | Why? |
| Uncertainty | 3 | 2021 | 1888 | 0.07 | Why? |
| Oxygen Inhalation Therapy | 1 | 2018 | 3629 | 0.07 | Why? |
| Opioid-Related Disorders | 1 | 2017 | 1185 | 0.07 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.07 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2021 | 2963 | 0.07 | Why? |
| Anti-HIV Agents | 1 | 2017 | 2209 | 0.07 | Why? |
| Nursing Staff, Hospital | 1 | 2018 | 1554 | 0.07 | Why? |
| Peer Group | 1 | 2008 | 402 | 0.07 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.07 | Why? |
| Patient Compliance | 1 | 2014 | 1468 | 0.07 | Why? |
| Patient Selection | 2 | 2019 | 4560 | 0.07 | Why? |
| World Health Organization | 3 | 2021 | 4213 | 0.06 | Why? |
| Secondary Prevention | 2 | 2018 | 762 | 0.06 | Why? |
| Sensitivity and Specificity | 3 | 2020 | 22971 | 0.06 | Why? |
| Adaptation, Psychological | 2 | 2018 | 4996 | 0.06 | Why? |
| Occupational Diseases | 1 | 2018 | 2787 | 0.06 | Why? |
| Vulnerable Populations | 1 | 2017 | 3099 | 0.06 | Why? |
| ROC Curve | 3 | 2020 | 6024 | 0.06 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.06 | Why? |
| Dissociative Disorders | 1 | 2021 | 28 | 0.06 | Why? |
| Pandemics | 9 | 2020 | 389249 | 0.06 | Why? |
| Area Under Curve | 2 | 2020 | 2564 | 0.06 | Why? |
| Inpatients | 1 | 2017 | 5161 | 0.06 | Why? |
| Severity of Illness Index | 6 | 2020 | 48226 | 0.06 | Why? |
| Skin Diseases | 1 | 2018 | 2509 | 0.05 | Why? |
| Educational Measurement | 1 | 2008 | 930 | 0.05 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.05 | Why? |
| Treatment Outcome | 7 | 2021 | 51732 | 0.05 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2017 | 5164 | 0.05 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.05 | Why? |
| Rotator Cuff | 1 | 2019 | 15 | 0.05 | Why? |
| Attitude of Health Personnel | 1 | 2018 | 4741 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.05 | Why? |
| Teaching | 1 | 2008 | 1208 | 0.05 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.05 | Why? |
| Shoulder | 1 | 2019 | 96 | 0.05 | Why? |
| Male | 11 | 2021 | 367725 | 0.05 | Why? |
| Epidemiologic Studies | 1 | 2021 | 554 | 0.05 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.05 | Why? |
| Recurrence | 2 | 2018 | 3675 | 0.05 | Why? |
| Patient Discharge | 1 | 2014 | 5696 | 0.05 | Why? |
| Post-Dural Puncture Headache | 1 | 2018 | 33 | 0.04 | Why? |
| Therapies, Investigational | 1 | 2020 | 235 | 0.04 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.04 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.04 | Why? |
| Aged | 9 | 2021 | 215776 | 0.04 | Why? |
| Sick Leave | 1 | 2021 | 318 | 0.04 | Why? |
| Fluorescent Antibody Technique | 1 | 2020 | 835 | 0.04 | Why? |
| Publication Bias | 1 | 2018 | 241 | 0.04 | Why? |
| Thyrotropin | 1 | 2019 | 262 | 0.04 | Why? |
| Urinary Incontinence | 1 | 2018 | 148 | 0.04 | Why? |
| Length of Stay | 3 | 2020 | 11042 | 0.04 | Why? |
| Tibial Fractures | 1 | 2017 | 32 | 0.04 | Why? |
| Thyroxine | 1 | 2019 | 250 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| Erectile Dysfunction | 1 | 2018 | 141 | 0.04 | Why? |
| Prognosis | 2 | 2017 | 32490 | 0.04 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Medical Overuse | 1 | 2018 | 146 | 0.04 | Why? |
| Work-Life Balance | 1 | 2018 | 212 | 0.04 | Why? |
| Diffusion of Innovation | 1 | 2020 | 440 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Immune Sera | 1 | 2020 | 884 | 0.04 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.04 | Why? |
| Social Capital | 1 | 2018 | 159 | 0.04 | Why? |
| Education, Medical, Undergraduate | 1 | 2008 | 1392 | 0.04 | Why? |
| Insurance, Health, Reimbursement | 1 | 2017 | 205 | 0.04 | Why? |
| Hospital Mortality | 2 | 2020 | 22087 | 0.04 | Why? |
| Hospitals | 1 | 2014 | 11793 | 0.03 | Why? |
| Prosthesis Design | 1 | 2017 | 594 | 0.03 | Why? |
| Drainage | 1 | 2018 | 414 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2018 | 657 | 0.03 | Why? |
| Longitudinal Studies | 2 | 2021 | 9893 | 0.03 | Why? |
| Probability | 1 | 2018 | 923 | 0.03 | Why? |
| Diagnosis-Related Groups | 1 | 2014 | 167 | 0.03 | Why? |
| Pain Measurement | 1 | 2017 | 533 | 0.03 | Why? |
| Costs and Cost Analysis | 1 | 2018 | 694 | 0.03 | Why? |
| Data Accuracy | 1 | 2019 | 715 | 0.03 | Why? |
| Risk Factors | 3 | 2018 | 71621 | 0.03 | Why? |
| Oximetry | 1 | 2018 | 658 | 0.03 | Why? |
| Standard of Care | 1 | 2020 | 1297 | 0.03 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.03 | Why? |
| Health Expenditures | 1 | 2020 | 904 | 0.03 | Why? |
| Quality of Life | 3 | 2019 | 9820 | 0.03 | Why? |
| Job Satisfaction | 1 | 2018 | 647 | 0.03 | Why? |
| False Positive Reactions | 1 | 2018 | 1338 | 0.03 | Why? |
| Death, Sudden, Cardiac | 1 | 2017 | 522 | 0.03 | Why? |
| Organizational Policy | 1 | 2017 | 694 | 0.03 | Why? |
| Decision Support Techniques | 1 | 2019 | 903 | 0.03 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.03 | Why? |
| Health Facilities | 1 | 2020 | 1230 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.03 | Why? |
| Consumer Behavior | 1 | 2018 | 544 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.03 | Why? |
| Female | 10 | 2021 | 380317 | 0.03 | Why? |
| Evidence-Based Practice | 1 | 2017 | 693 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2017 | 1475 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Primary Prevention | 1 | 2017 | 778 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.02 | Why? |
| Adult | 7 | 2021 | 244371 | 0.02 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2021 | 1766 | 0.02 | Why? |
| Hospitals, Pediatric | 1 | 2020 | 1792 | 0.02 | Why? |
| Students, Medical | 1 | 2008 | 4032 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.02 | Why? |
| Interviews as Topic | 1 | 2018 | 1952 | 0.02 | Why? |
| Antimalarials | 1 | 2021 | 2505 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.02 | Why? |
| Fatigue | 1 | 2019 | 2479 | 0.02 | Why? |
| Delivery of Health Care | 1 | 2014 | 15909 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Equipment Design | 1 | 2018 | 3095 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Body Mass Index | 1 | 2019 | 4306 | 0.02 | Why? |
| Qualitative Research | 1 | 2018 | 4337 | 0.02 | Why? |
| Health Occupations | 1 | 2008 | 235 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.02 | Why? |
| Oxygen | 1 | 2018 | 3715 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.02 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.02 | Why? |
| Quality Improvement | 1 | 2017 | 2435 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.02 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.02 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| China | 2 | 2020 | 50654 | 0.02 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Odds Ratio | 1 | 2014 | 5861 | 0.02 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.01 | Why? |
| Child | 2 | 2020 | 70012 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2019 | 5002 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.01 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2014 | 11304 | 0.01 | Why? |
| Incidence | 1 | 2019 | 25622 | 0.01 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Depression | 1 | 2019 | 14116 | 0.01 | Why? |
| Critical Illness | 1 | 2018 | 17281 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.01 | Why? |
| Public Health | 1 | 2017 | 16359 | 0.01 | Why? |
| Animals | 1 | 2021 | 78931 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |